Form 4: Acelyrin Director Henry O. Gosebruch Acquires Stock Options

Director Henry O. Gosebruch acquired stock options in Acelyrin, Inc. on June 7, 2024.

Summary

• On June 7, 2024, Henry O. Gosebruch, a director of Acelyrin, Inc., acquired stock options to purchase 92,158 shares of common stock at an exercise price of $4.46 per share.
• The options vest on the earlier of June 7, 2025, or the day before the next annual meeting of stockholders, contingent upon continued service as a director.
• Following the transaction, Gosebruch directly owns options for 92,158 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director suggests confidence in the company, but it's a routine transaction.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.

Key Dates